OncoSpear ApS: Financial statements 2023
CVR: 42093734
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
OncoSpear ApS (CVR 42093734) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -5,395,986 and a net result of DKK -6,694,240 compared with DKK -1,090,059 the year before. Equity in the 2023 report amounted to DKK 7,852,765. The solvency ratio was 84.9%. The company had 5 employees in the financial year.
- Gross Profit
- DKK -5,395,986
- Profit/Loss
- DKK -6,694,240
- Equity
- DKK 7,852,765
- Total Assets
- DKK 9,253,130
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -5.4M | -6.7M | 7.9M | 5 |
| 2022 | - | -640K | -1.1M | 7.1M | 1 |
| 2021 | - | -26K | -26K | 24K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
OncoSpear ApS has published its annual report for 2022. Gross profit came to DKK -639,949, and the net result was DKK -1,090,059.
As of June 27, 2023, Jens Kristian Damsgaard has left the board of directors of OncoSpear ApS.
As of June 22, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of OncoSpear ApS.
As of January 2, 2023, Søren Kragh Moestrup has joined the board of directors of OncoSpear ApS.
As of January 2, 2023, Debora Catharina Dumont has joined the board of directors of OncoSpear ApS.
As of January 1, 2023, Søren Kragh Moestrup has left the board of directors of OncoSpear ApS.
As of January 1, 2023, Debora Catharina Dumont has left the board of directors of OncoSpear ApS.
About OncoSpear ApS
OncoSpear ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2021. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Geert Gilbert Tackaert and Niels Jonas Heilskov Graversen. The company is owned by SPICA THERAPEUTICS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 2,927,421 and a net result of DKK -821,765 compared with DKK -6,461,139 the year before. Equity in the 2025 report amounted to DKK 569,861.